Clinical Trials List
Protocol NumberTAK-226-3001
Not yet recruiting
2026-05-01 - 2034-12-31
Phase III
Not yet recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Wen-Chien Chou Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- - - Division of General Internal Medicine
- - - Division of General Internal Medicine
- YAO CHI-YUAN Division of Others -
- 楊鎰聰 Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- Tai-Chung Huang Division of General Internal Medicine
- 李婉瑄 Division of General Internal Medicine
- 李思慧 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
210-300 participants
